- Filed
- Apr 22, 2020 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Apr 20, 2020 | 254.3M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2020 | 266.79M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 265.21M sh |
| Capex | Q1 2020 · Mar 31, 2020 | $4.79M |
| Capex | Q1 2020 · Mar 31, 2019 | $4.37M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | $115.91M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | $96.01M |
| Short Term Debt | Q1 2020 · Mar 31, 2020 | $6.66M |
| Short Term Debt | Q1 2020 · Dec 31, 2019 | $6.84M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $140.32M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $36.62M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $290.67M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $341.71M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $189.22M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $156M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $317.42M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $349.98M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $1.41B |
| Total Assets | Q1 2020 · Dec 31, 2019 | $1.45B |
| Eps Diluted | Q1 2020 · Mar 31, 2020 | $0.02 |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | $0.03 |
| Eps Basic | Q1 2020 · Mar 31, 2020 | $0.02 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | $0.03 |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $28.85M |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $24.89M |
| Net Income | Q1 2020 · Mar 31, 2020 | $9.04M |
| Net Income | Q1 2020 · Mar 31, 2019 | $11.76M |
| Operating Income | Q1 2020 · Mar 31, 2020 | $26.2M |
| Operating Income | Q1 2020 · Mar 31, 2019 | $27.64M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $88.77M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $94.03M |
| Revenue | Q1 2020 · Mar 31, 2020 | $143.82M |
| Revenue | Q1 2020 · Mar 31, 2019 | $146.56M |